Showing results (61-70 of 290) with videos related to
Sort By:
Pageof 29
International Immunology|January 14, 1999
Molecular modeling of hen egg lysozyme HEL[52-61] peptide binding to I-Ak MHC class II moleculeP Weber, I Raynaud, L Ettouati, et al.International Journal of Tissue Reactions|January 1, 1993
Clinical pharmacology of oxicams: new insights into the mechanisms of their dose-dependent toxicityE Albengres, S Urien, J Barre, et al.Journal of Medicinal Chemistry|August 1, 1997
H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazolesM Mor, F Bordi, C Silva, et al.Free Radical Biology & Medicine|July 9, 1998
Structure-property relationships of trimetazidine derivatives and model compounds as potential antioxidantsJ Ancerewicz, E Migliavacca, P A Carrupt, et al.Animal : an International Journal of Animal Bioscience|September 29, 2022
Implementation of hypocalcaemia prevention programmes in commercial dairy herds: From theory to practiceT Aubineau, R Guatteo, A BoudonJDS Communications|September 23, 2024
Interaction between drinker density and cow social dominance affects drinking behaviorE Nizzi, C Hurtaud, A BoudonJournal of Medicinal Chemistry|January 6, 1995
X-ray crystal structure, partitioning behavior, and molecular modeling study of piracetam-type nootropics: insights into the pharmacophoreC Altomare, S Cellamare, A Carotti, et al.Biochemical Pharmacology|January 1, 1988
Substrate and product stereoselectivity in monooxygenase-mediated drug activation and inactivationB TestaSchweizerische Medizinische Wochenschrift|June 30, 1990
[Chiral drugs: pharmacological tools and/or therapeutic problems?]B TestaXenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1990
Mechanisms of inhibition of xenobiotic-metabolizing enzymesB TestaPageof 29